{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:48:47Z","timestamp":1785858527144,"version":"3.56.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1097\/01.gme.0000148644.55486.36","type":"journal-article","created":{"date-parts":[[2005,7,22]],"date-time":"2005-07-22T06:30:19Z","timestamp":1122013819000},"page":"399-404","source":"Crossref","is-referenced-by-count":41,"title":["Hormone use and patient concerns after the findings of the Women's Health Initiative"],"prefix":"10.1097","volume":"12","author":[{"given":"Sharon J","family":"Rolnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Kopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese A","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3949\/ccjm.68.5.441","article-title":"Coronary artery disease in women: different, often undertreated.","volume":"68","author":"Jneid","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/archinte.160.21.3315","article-title":"Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.","volume":"160","author":"Davidson","year":"2000","journal-title":"Arch Intern Med"},{"key":"R4-8-20210227","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1532-5415.2001.49040.x","article-title":"Hormone replacement therapy and fractures in older adults.","volume":"49","author":"Kamel","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials.","volume":"285","author":"Torgerson","year":"2001","journal-title":"JAMA"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0002-9343(99)00063-7","article-title":"Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.","volume":"106","author":"Grodstein","year":"1999","journal-title":"Am J Med"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.285.11.1489","article-title":"Hormone replacement therapy and cognition: systematic review and meta-analysis.","volume":"285","author":"LeBlanc","year":"2001","journal-title":"JAMA"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.281.13.1197","article-title":"Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.","volume":"281","author":"Shaywitz","year":"1999","journal-title":"JAMA"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-5122(95)00921-7","article-title":"Compliance with long-term oral hormonal replacement therapy.","volume":"22","author":"Eiken","year":"1995","journal-title":"Maturitas"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00042192-199603020-00008","article-title":"Womens reasons for using postmenopausal hormone replacement therapy: preventive medicine or therapeutic aid?","volume":"3","author":"Jeffe","year":"1996","journal-title":"Menopause"},{"key":"R11-8-20210227","first-page":"59","article-title":"Keynote Address: The North American Menopause Society Annual Meeting 1994.","volume":"2","author":"Andrews","year":"1995","journal-title":"Menopause"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/hc2901.092200","article-title":"Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.","volume":"104","author":"Mosca","year":"2001","journal-title":"Circulation"},{"key":"R15-8-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.10.6.1051","article-title":"Inhibition of coronary artery atherosclerosis by 17ss-estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.","volume":"10","author":"Adams","year":"1990","journal-title":"Arteriosclerosis"},{"key":"R20-8-20210227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.ATV.17.1.217","article-title":"Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis.","volume":"17","author":"Adams","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-8-20210227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.273.3.199","article-title":"The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R22-8-20210227","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0735-1097(94)90184-8","article-title":"Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys.","volume":"24","author":"Williams","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"R23-8-20210227","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study.","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"R24-8-20210227","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-95-1-28","article-title":"Menopausal estrogen therapy and hip fractures.","volume":"95","author":"Paganini-Hill","year":"1981","journal-title":"Ann Intern Med"},{"key":"R25-8-20210227","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-102-3-319","article-title":"Long-term estrogen replacement therapy prevents bone loss and fractures.","volume":"102","author":"Ettinger","year":"1985","journal-title":"Ann Intern Med"},{"key":"R26-8-20210227","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Womens Health Initiative randomized trial.","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"R27-8-20210227","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.289.19.2525","article-title":"Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.","volume":"289","author":"Greenspan","year":"2003","journal-title":"JAMA"},{"key":"R28-8-20210227","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.GME.0000086467.82759.DA","article-title":"Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.","volume":"10","author":"Barrett-Connor","year":"2003","journal-title":"Menopause"},{"key":"R29-8-20210227","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/archinte.1996.00440180075009","article-title":"Estrogen replacement therapy and risk of Alzheimer disease.","volume":"156","author":"Paganini-Hill","year":"1996","journal-title":"Arch Intern Med"},{"key":"R30-8-20210227","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.48.6.1517","article-title":"A prospective study of estrogen replacement therapy and the risk of developing Alzheimers disease: the Baltimore Longitudinal Study of Aging.","volume":"48","author":"Kawas","year":"1997","journal-title":"Neurology"},{"key":"R31-8-20210227","first-page":"125","article-title":"Low-dose estrogen replacement therapy for Alzheimer disease in women.","volume":"1","author":"Ohkura","year":"1994","journal-title":"Menopause"},{"key":"R32-8-20210227","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"R33-8-20210227","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Rapp","year":"2003","journal-title":"JAMA"},{"key":"R34-8-20210227","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1001\/archinte.163.20.2485","article-title":"Postmenopausal hormone therapy and its association with cognitive impairment.","volume":"163","author":"Mitchell","year":"2003","journal-title":"Arch Intern Med"},{"key":"R35-8-20210227","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1532-5415.2004.52053.x","article-title":"Hormone use and cognitive performance in women of advanced age.","volume":"52","author":"Galen Buckwalter","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R36-8-20210227","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMp030038","article-title":"Postmenopausal hormones-therapy for symptoms only.","volume":"348","author":"Grady","year":"2003","journal-title":"N Engl J Med"},{"key":"R37-8-20210227","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Womens Health Initiative Memory Study.","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"key":"R38-8-20210227","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Womens Health Initiative Memory Study.","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"R39-8-20210227","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.287.5.591","article-title":"Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen\/Progestin Replacement Study (HERS) trial.","volume":"287","author":"Hlatky","year":"2002","journal-title":"JAMA"},{"key":"R40-8-20210227","first-page":"982","article-title":"Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen\/Progestin Interventions Trial.","volume":"92","author":"Greendale","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R42-8-20210227","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life.","volume":"348","author":"Hays","year":"2003","journal-title":"N Engl J Med"},{"key":"R43-8-20210227","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women: the Womens Health Initiative: a randomized trial.","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"R44-8-20210227","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease.","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"R45-8-20210227","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1503\/cmaj.1030755","article-title":"Recommendation statement from the Canadian Task Force on Preventive Health Care.","volume":"170","year":"2004","journal-title":"CMAJ"},{"key":"R46-8-20210227","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.","volume":"349","author":"Hodis","year":"2003","journal-title":"N Engl J Med"},{"key":"R47-8-20210227","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMp038108","article-title":"From presumed benefit to potential harm-hormone therapy and heart disease.","volume":"349","author":"Herrington","year":"2003","journal-title":"N Engl J Med"},{"key":"R49-8-20210227","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bmj.328.7436.357","article-title":"Where are we now with hormone replacement therapy?","volume":"328","author":"McPherson","year":"2004","journal-title":"BMJ"},{"key":"R51-8-20210227","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/107155760200900501","article-title":"The impact of the Womens Health Initiative on clinical practice.","volume":"9","author":"Speroff","year":"2002","journal-title":"J Soc Gynecol Investig"},{"key":"R52-8-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence.","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"R53-8-20210227","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-140-3-200402030-00009","article-title":"Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results.","volume":"140","author":"Haas","year":"2004","journal-title":"Ann Intern Med"},{"key":"R54-8-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200205000-00003","article-title":"A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century.","volume":"9","author":"Rodstrom","year":"2002","journal-title":"Menopause"},{"key":"R55-8-20210227","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.GME.0000094541.07420.7C","article-title":"Estrogen-no matter how delivered-relieves postmenopausal vasomotor symptoms.","volume":"10","author":"Bachmann","year":"2003","journal-title":"Menopause"},{"key":"R56-8-20210227","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.GME.0000058147.24036.B0","article-title":"A systematic review of herbal medicinal products for the treatment of menopausal symptoms.","volume":"10","author":"Huntley","year":"2003","journal-title":"Menopause"},{"key":"R57-8-20210227","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1067\/S0002-9378(03)00778-6","article-title":"Decision analysis of hormone replacement therapy after the Womens Health Initiative.","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.GME.0000148644.55486.36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:54:48Z","timestamp":1785855288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200512040-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.gme.0000148644.55486.36","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}